Third-quarter 2011 IBO Life Science Index sales grew 6.7%, 4.6% excluding currency, to $3,149.7 million. Operating profit improved 2.1% to $641.8 million, and operating margin slipped 90 basis points to 21.4% of sales. Fiscal fourth-quarter revenue for Becton Dickinson’s BD Biosciences division grew 9.6%, 4.7% excluding currency, to $354.2 million to account for 17% of […]
For most of November, global equity prices slumped due to heightened apprehensions over European sovereign debt and unsustainable Treasury bond yields for those debt-ridden countries. In the US, positive economic data for the consumer sector and manufacturing was overshadowed by Europe and uncertainty surrounding the Congressional budget reduction. However, amid the anguish, the Federal Reserve […]
Venlo, The Netherlands 11/28/11—QIAGEN has announced an effort to streamline its organizational structures that will result in an 8%–10% reduction in its 3,800-person workforce. Actions include the elimination of duplicate global, regional and local activities; the discontinuation of certain R&D programs in order to focus on high-growth areas; improved site utilization; and the expansion of […]
Slower academic and government spending continued into the calendar-year third quarter, with mixed effects on the eight businesses whose quarterly results are profiled on pages 9–11. Industrial and applied markets stayed strong, as did Asia, helping sustain momentum for all companies, with the exception of Illumina. Combined sales growth for the eight businesses (including a […]
The US fiscal year 2012 began in October, but details of the federal government’s budget are still being ironed out. The $193 billion fiscal 2012 “minibus” appropriations bill, which covers five federal departments and various independent agencies, was passed by the House and Senate on November 17 and signed by President Obama the next day. […]
Company Announcements GE announced in its quarterly conference call that second-quarter sales for GE Healthcare Life Sciences increased 7%. Sigma-Aldrich’s second-quarter sales grew 15.0% to $637.0 million (see IBO 7/31/11) or 6% organically. Currency effects and acquisitions increased sales 7.8% and 1.6%, respectively. Research Essentials, Research Specialties, Research Biotech and Fine Chemicals revenues grew 17%, […]
Third-quarter revenues for IBO’s Laboratory Instrument Sales Index grew 8.5% to $5,761.23 million, including 2.6% growth from currency. Operating profit improved 11.3% to $1,167.67 million, but operating margin slipped 100 basis points to 18.9% of sales. For the three companies (Analytik Jena, Spectris and Tecan) that did not report earnings before this issue’s publication, estimates […]
Abingdon, UK 11/4/11—Oxford Instruments has announced the acquisition of Platinum Medical Imaging for $18 million and an additional $37 million in deferred payments based on the business’s performance over three years. US-based Platinum Medical Imaging provides parts and services for MRI and computed tomography medical imaging instruments. The company’s 2010 revenues were $14.1 million, and […]
San Jose, CA 10/19/11—Measurement instrument firm Endress+Hauser has acquired a stake in Finesse Solutions, a developer and producer of sensors, hardware and software for bioprocess engineering. Skymoon Ventures, the previous majority shareholder, will hold an equal stake to Endress+Hauser and the company’s staff of about 50 will maintain their ownership stake. “Biotechnological procedures will play […]
San Diego, CA 10/25/11; Washington, DC 10/26/11—Illumina announced in its third-quarter earnings release (see page 4) that it has implemented a restructuring program due to the uncertainties surrounding government and academic research funding and the global economic environment. The company expects to record the majority of a $15–$17 million restructuring charge in the fourth quarter. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
